Ingredient | Grade | Studies | ||||||
---|---|---|---|---|---|---|---|---|
Quassia Extract |
D
|
|
||||||
Tretinoin |
E
|
|
||||||
Azelaic Acid + Gluconolactone |
E
|
|
||||||
Kinetin |
E
|
|
||||||
Azelaic Acid |
E
|
|
Product | Grade | Studies | ||||||
---|---|---|---|---|---|---|---|---|
Imedeen |
D
|
|
||||||
Renova |
D
|
|
||||||
Imedeen Prime Renewal |
D
|
|
||||||
Cellex-C High-Potency Serum |
D
|
|
||||||
Imedeen Time Perfection |
D
|
|
Skincare treatments can penetrate more deeply into the skin to provide faster, more dramatic and longer-lasting results than topical products, but they are also much more expensive.
Review all of the scientific evidence before spending thousands of dollars on treatments that won't work, or that make your skin worse due to the side effects.
Log in to register your interest in knowing when information on skincare treatments becomes available on Wisderm.com, and get a 20% discount on launch!
Intervention | Tretinoin |
---|---|
Concern | Spider Veins |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 168 days |
Participants | 299 |
Intervention | Azelaic Acid |
---|---|
Concern | Spider Veins |
Subject Type | Human |
Trial Design |
Single-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 67 |
Intervention | Azelaic Acid |
---|---|
Concern | Spider Veins |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 116 |
Intervention | Azelaic Acid |
---|---|
Concern | Spider Veins |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 105 days |
Participants | 251 |
Intervention | Azelaic Acid |
---|---|
Concern | Spider Veins |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 664 |
Intervention | Azelaic Acid |
---|---|
Concern | Spider Veins |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 105 days |
Participants | 40 |
Intervention | Metronidazole |
---|---|
Concern | Spider Veins |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 105 days |
Participants | 251 |